Almost 30 years on from the discovery of the genetic defect that causes cystic fibrosis, treatment options are still limited and growing antibiotic resistance presents a grave threat. Now, a team of researchers from across Cambridge, in a major new centre supported by the Cystic Fibrosis Trust, hopes to turn fortunes around.
Cambridge Academy of Therapeutic Sciences receives Wellcome funding to support translational research05 Dec 2017
The Cambridge Academy of Therapeutic Sciences (CATS) has been awarded £1million over two years by Wellcome as a part of a new scheme to find new ways to translate scientific discoveries into real world impact.
“The best or worst thing to happen to humanity” - Stephen Hawking launches Centre for the Future of Intelligence19 Oct 2016
Artificial intelligence has the power to eradicate poverty and disease or hasten the end of human civilisation as we know it – according to a speech delivered by Professor Stephen Hawking this evening.
"The Postdoc Centre is an important development for a very large group of staff" - Professor Chris Abell.
A new programme offered by the Institute of Continuing Education will give participants a rare insight into the challenges involved in pushing back the frontiers of science. Given by five specialists in different fields, ‘Cambridge science: behind the scenes’ starts in January 2014.
A new, single-step method of fabricating microcapsules, which have potential commercial applications in industries including medicine, agriculture and diagnostics, has been developed by researchers at the University of Cambridge. The findings are published Friday (10 February) in the journal Science.
An innovative new project spearheaded by Cambridge Enterprise Ltd and researchers in the Department of Chemistry is taking a proactive approach to intellectual property (IP) and commercialisation.